Clinical Infectious Diseases AI Policy: ChatGPT and Generative AI Disclosure Rules for CID Authors
Clinical Infectious Diseases (Oxford University Press) requires AI disclosure under the publisher rules. AI cannot be an author. This guide covers where to disclose, what to disclose, and the consequences of non-compliance for CID submissions.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Clinical Infectious Diseases at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 7.3 puts Clinical Infectious Diseases in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~25-35% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Clinical Infectious Diseases takes ~~90-120 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick answer: The Clinical Infectious Diseases AI policy follows the publisher's rules calibrated to practice-changing infectious-disease research submissions. AI tools can be used for manuscript preparation but every use must be disclosed in the Methods section, with CID's editorial team checking specifics at desk-screen. AI cannot be listed as an author of any CID paper. AI-generated figures and schematics representing original research data are prohibited under CID's image-integrity standard. Clinical Infectious Diseases (Oxford University Press) editors treat undisclosed use as a publication-ethics violation per ICMJE + COPE.
Run the CID submission readiness check which includes an automated AI-disclosure audit, or work through this guide manually. Need broader context? See the CID journal overview.
The Manusights CID readiness scan. This guide tells you what Clinical Infectious Diseases (Oxford University Press)'s editors look for when verifying AI disclosure at desk-screen. The scan tells you whether YOUR Methods section has the required language before you submit. We have reviewed manuscripts targeting Clinical Infectious Diseases (Oxford University Press) and peer venues; the named patterns below are the same ones Sharon Hammes-Schiffer and the journal's editorial AI committee flag at the desk-screen and editorial-board consultation stages. 60-day money-back guarantee. We do not train AI on your manuscript and delete it within 24 hours.
Editorial detail (for desk-screen calibration). Editor-in-Chief: Sharon Hammes-Schiffer (Oxford University Press) leads CID editorial decisions. Editorial-board listings change; verify the current incumbent at the journal's editorial-team page before quoting the name in a submission cover letter. Submission portal: https://mc.manuscriptcentral.com/cid. Manuscript constraints: 250-word abstract limit and 3,500-word main-text cap (CID enforces during desk-screen). We reviewed the publisher's AI policy framework against current CID author guidelines (accessed 2026-05-08); evidence basis includes both publicly documented the publisher policy and our internal anonymized submission corpus. The applicable word limit at CID is shown below: 250-word abstract limit and 3,500-word main-text cap (CID enforces during desk-screen).
Verify exact word and figure limits against the latest author guidelines before submission. The named editorial-culture quirk: CID editors enforce practice-changing-evidence threshold; mechanism-only papers without immediate clinical-translation pathway extend revision.
What does Clinical Infectious Diseases (Oxford University Press)'s AI policy require?
CID authors must follow four rules under the publisher's AI framework, all enforced at desk-screen:
Rule 1: Disclose every AI tool used in manuscript preparation
Authors must name every generative AI tool used, its version, and how it was used. The disclosure goes in the Methods section, not the Acknowledgments. Examples that REQUIRE disclosure at CID:
- For CID-targeted manuscripts addressing practice-changing infectious-disease research: using ChatGPT, Claude, Gemini, or similar to draft, polish, or edit manuscript text passing through CID editorial review
- For CID submissions: using AI to generate boilerplate text for limitations, ethics statements, or CID-specific response-to-reviewers letters that cite the publisher's framework
- For Clinical Infectious Diseases (Oxford University Press) submissions: using AI to translate manuscript text into English from another language, with the publisher expecting disclosure of the source language and translation chain
- For CID literature reviews: using AI for citation discovery or summarizing prior CID work; the publisher's policy applies regardless of citation context
- For CID analytical pipelines: AI-assisted code generation requires Methods + code disclosure under ICMJE + COPE, particularly when code touches practice-changing infectious-disease research analysis
Examples that do NOT require AI disclosure:
- At CID, using grammar/spell checkers (Word, Grammarly basic) that do not generate new content for the manuscript
- For CID submissions, using reference managers (Zotero, EndNote) for citation formatting against the publisher's style guide
- For Clinical Infectious Diseases (Oxford University Press) statistical analysis, using established statistical software (R, Stata, SPSS) where the algorithm is the established tool documented in CID's methodological norm, not a generative AI
Rule 2: AI cannot be an author
No AI tool can be listed as an author of a CID paper, particularly for practice-changing infectious-disease research-class submissions. Under the publisher's policy: authorship requires the ability to take responsibility for the content, agree to be accountable for accuracy, and to consent to publication. AI tools cannot do any of these in CID's editorial framework. This rule is consistent across all the publisher-published journals and applied at CID's desk-screen.
Rule 3: AI-generated figures are prohibited for original research data
Clinical Infectious Diseases (Oxford University Press) editorial team does not accept AI-generated images, figures, or schematics that represent original research data in practice-changing infectious-disease research-class submissions. AI tools may assist with figure layout (axis labeling, color schemes) but the underlying data visualization must come from the actual research. AI-generated diagrams used for conceptual illustrations (e.g., a schematic of a hypothesized mechanism) require explicit disclosure and a statement that the diagram is conceptual.
Rule 4: Disclose AI use in peer review participation
Reviewers writing reports for CID cannot use generative AI to draft their reports without disclosing it to the editor. Some the publisher journals prohibit AI-assisted reviewing entirely; CID follows the publisher's default of disclosure-required. The editor decides whether the report is acceptable based on disclosure.
How does Clinical Infectious Diseases (Oxford University Press)'s AI policy compare to peer journals?
Rule | CID stance | the publisher default | ICMJE/COPE alignment |
|---|---|---|---|
AI authorship | Prohibited | Prohibited | ICMJE-aligned |
Disclosure location | Methods section | Methods section | ICMJE-aligned |
AI-generated figures | Prohibited for original data | Prohibited | COPE image-integrity-aligned |
Reviewer AI use | Disclosure required | Disclosure required | COPE peer-review-aligned |
Enforcement intensity | Desk-screen check | Desk-screen check | Pre-publication enforcement |
Source: (accessed 2026-05-08) plus CID author guidelines.
What does AI disclosure look like in a CID Methods section?
Acceptable disclosure language for CID submissions:
"For our practice-changing infectious-disease research-focused manuscript at CID, we used ChatGPT-4o (OpenAI, version dated October 2024) to polish English-language phrasing in the Introduction and Discussion sections. We did not use generative AI for data analysis, figure generation, or substantive manuscript content. All authors reviewed and edited the AI-assisted text and take responsibility for the final manuscript."
Or, for AI-assisted code:
"For this CID submission addressing practice-changing infectious-disease research, initial Python code for the Bayesian regression analysis was drafted with Claude 3.5 Sonnet (Anthropic, version dated December 2024). All code was reviewed, modified, and validated by the authors before use; the final version is available at [repository URL]. Statistical inference was performed using the established R package brms."
What does NOT pass CID's desk-screen:
- For CID addressing practice-changing infectious-disease research: "AI tools were used in manuscript preparation." Too vague for the publisher editorial review of CID submissions; the CID editorial team needs the specific tool name, version, and specific use case
- "We acknowledge AI assistance in the Acknowledgments." (Wrong location; must be Methods)
- "ChatGPT helped write this paper." (Insufficient detail on use case)
- No disclosure when AI was used (publication-ethics violation)
What do pre-submission reviews reveal about CID's AI-disclosure desk-screen failures?
In our pre-submission review work on CID-targeted manuscripts, three patterns most consistently predict AI-policy desk-screen flags at Clinical Infectious Diseases (Oxford University Press). Of the manuscripts we screened in 2025 targeting CID and peer venues, the patterns below are the same ones the journal's editorial AI committee flags during editorial review.
AI disclosure missing despite obvious AI-assisted phrasing. CID editors identify AI-drafted text by patterns like overuse of em-dashes, formulaic transitions ("In conclusion," "Furthermore"), and uniform sentence length variance. When the manuscript shows these patterns but contains no AI disclosure, it triggers an editorial query. Check whether your manuscript reads as AI-assisted
AI disclosure in Acknowledgments instead of Methods. CID editorial team flags this as a common mistake against practice-changing infectious-disease research submissions. The publisher's policy specifies Methods placement so that the disclosure is part of the methodological record, not a courtesy under CID's editorial culture. Misplaced disclosures get flagged at desk-screen and require resubmission. Check whether your AI disclosure is in the right section
Generic disclosure language without tool name and version. CID editorial team requires the specific tool, its version (or access date), and the specific use case. "AI tools were used" without specifics gets returned. Check whether your AI disclosure has the required specificity
What is the CID AI-policy compliance timeline?
Stage | Duration | What happens |
|---|---|---|
Author drafts AI disclosure | 30-60 minutes | Identify all AI use, gather tool versions, write Methods paragraph |
Co-author review of disclosure | 1-2 days | All authors confirm the disclosure is complete and accurate |
Editorial desk-screen check | 1-2 weeks | CID's editorial team verifies disclosure against the manuscript |
Editorial query (if disclosure incomplete) | 5-10 days | Editor requests revision before sending to peer review |
Reviewer AI-disclosure check | During peer review | Reviewers verify the disclosure matches the manuscript style |
Source: Manusights internal review of CID-targeted submissions, 2025 cohort.
Submit If
- For Clinical Infectious Diseases (Oxford University Press) submissions on practice-changing infectious-disease research: the manuscript explicitly discloses every AI tool used, with name, version, and specific use case in the Methods section, calibrated to CID's editorial expectations
- For CID: no AI tool is listed as an author; all listed authors meet ICMJE authorship criteria, agree to take responsibility, and the publisher expects this acknowledgment in the cover letter
- For Clinical Infectious Diseases (Oxford University Press): figures and schematics representing original research data come from the actual research, not AI generation, with CID editorial team checking image-integrity at desk-screen
- For CID submissions: the disclosure includes a statement that all human authors reviewed and edited the AI-assisted text, with the publisher requiring this acknowledgment per ICMJE + COPE
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Think Twice If
- The manuscript shows AI-drafted text patterns (em-dash overuse, formulaic transitions) but contains no AI disclosure; CID desk-screen will flag this.
- The AI disclosure is in the Acknowledgments instead of the Methods section, against the publisher's explicit guidance.
- The disclosure language is generic ("AI tools were used") without specifying tool name, version, and use case; CID editors return manuscripts with this gap.
- Any figure or schematic representing original research data was generated by AI; CID prohibits this regardless of disclosure.
Manusights submission-corpus signal for Clinical Infectious Diseases (Oxford University Press). Of the manuscripts our team screened before submission to CID and peer venues in 2025, the AI-policy compliance gap most consistent across the cohort is generic disclosure language without tool-version specificity. In our analysis of anonymized CID-targeted submissions, manuscripts with complete AI disclosure (tool name, version, specific use case, all-author confirmation) clear desk-screen at the same rate as manuscripts without AI use; manuscripts with incomplete or missing disclosure trigger editorial queries that add 1-2 weeks to the timeline. The journal's editorial AI committee reviews disclosures against ICMJE + COPE framework requirements, and Clinical Infectious Diseases (Oxford University Press) applies that framework consistently with the publisher's broader policy. Recent retractions in the CID corpus include 10.1093/cid/ciac425, 10.1093/cid/ciab628, and 10.1093/cid/ciad189. Citing any of these without acknowledging the retraction is an automatic publication-ethics flag, separate from AI-disclosure issues.
What can CID authors do to stay ahead of AI policy changes?
the publisher's AI policy framework continues to evolve as 2026 brings new ICMJE recommendations, COPE guidance refinements, and journal-specific clarifications. CID authors targeting practice-changing infectious-disease research submissions should track three signals throughout 2026:
Quarterly policy updates from the publisher. the journal's editorial AI committee reviews the AI framework on a rolling basis. CID authors who pre-register their disclosure language at submission time tend to face fewer revisions during the 2026 transition period than authors who write boilerplate disclosures.
Field-specific clarifications for practice-changing infectious-disease research. Different research domains see different AI use patterns. CID's editorial team has been refining what counts as "substantive AI use" versus "ancillary AI assistance" for practice-changing infectious-disease research work. Authors who err on the side of more disclosure rather than less avoid the publication-ethics gray zone.
Reviewer disclosure norms. As the publisher extends AI-disclosure rules to peer reviewers, the response rate from CID reviewers may shift. Authors should expect that CID reviewers' use of AI tools is now also disclosed and factored into editorial decisions.
- Manusights internal preview corpus (2025 cohort)
Frequently asked questions
Yes, with mandatory disclosure. Clinical Infectious Diseases (Oxford University Press) follows the publisher's AI policy under the ICMJE + COPE framework. AI tools can be used for language editing, manuscript preparation, and analysis support, but all use must be disclosed in the Methods section. AI cannot be listed as an author, and human authors bear full responsibility for the content.
In the Methods section. Authors must name the specific AI tool (e.g., ChatGPT-4o, Claude 3.5 Sonnet), its version, and describe how it was used. The disclosure should confirm that all human authors reviewed and take responsibility for the AI-assisted content. CID's editorial team checks this disclosure during desk-screen.
No. Clinical Infectious Diseases (Oxford University Press) prohibits AI-generated figures, schematics, and images intended to represent original research data. AI tools may assist with figure layout and labeling, but the underlying data and visualizations must come from the actual research. This rule is part of the publisher's broader image-integrity policy.
CID treats undisclosed AI use as a publication-ethics violation following COPE guidelines. Consequences range from required correction to expression of concern or retraction, depending on severity. The publisher may notify the authors' institution in serious cases.
The core requirements (disclosure in Methods, no AI authorship, no AI-generated figures) are consistent across the publisher-published journals. CID applies these rules consistently with the publisher's broader policy framework. The journal-specific element is enforcement intensity at desk-screen, which at CID is calibrated by cid editors enforce practice-changing-evidence threshold.
Sources
- the publisher AI policy
- CID author guidelines (accessed 2026-05-08)
- ICMJE recommendations on AI use (accessed 2026-05-08)
- COPE guidance on AI in research publication (accessed 2026-05-08)
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
- Clinical Infectious Diseases Submission Guide: Scope, Format & Tips
- How to Avoid Desk Rejection at Clinical Infectious Diseases
- Is Clinical Infectious Diseases a Good Journal? Impact, Scope, and Fit
- Clinical Infectious Diseases Pre Submission Checklist: 12 Items Editors Verify Before Peer Review
- Clinical Infectious Diseases APC and Open Access: Current OUP Pricing, Page Charges, and When Gold OA Is Worth It
- Clinical Infectious Diseases Submission Process: What Happens From Upload to First Decision
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.